JAKARTA, INDONESIA--(Marketwire - Oct 26, 2012) - Moments ago, [ TradersInsight.net ] introduced new coverage of Celgene Corporation (NASDAQ: [ CELG ]) and Teva Pharmaceutical Industries Limited (NYSE: [ TEVA ]). Full outlook, analysis and consensus opinion is available to readers via the links below.

[ www.TradersInsight.net/r/cnbc/e51d_CELG ]
[ www.TradersInsight.net/r/cnbc/24c9_TEVA ]

The consistent delivery of accurate analyses relies solely on two factors, namely: market awareness and industry insight. Recent market drivers include a rise in new home sales to 5.7% in September to an annualized pace of 389,000 units, slightly stronger than market expectations for an increase to 385,000, recent confirmation of continued monetary stimulus and an unchanged FOMC policy and recent moderation of existing home sales in the US to 4.75 million annualized units in September 2012 from 4.83 million reported in the previous month. When it comes to discovering the right edge at the right time, all these factors play into effect. For a deeper understanding of the mechanics behind these events and how it can affect your portfolio, please refer to our email newsletter delivered to your inbox.

Traders Insight is releasing new coverage on Celgene Corporation for its current position within the consumer durables sector. Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases. A copy of this report featuring Celgene Corporation (NASDAQ: [ CELG ]) is available at: [ www.TradersInsight.net/r/cnbc/e51d_CELG ].

Traders Insight has released research on Teva Pharmaceutical Industries Limited for its changing role within the consumer durables sector. Teva Pharmaceutical Industries Ltd (Teva) is a global pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment categories. The Company has a pharmaceutical business, whose principal products include Copaxone and Azilect. To access the full research report on Teva Pharmaceutical Industries Limited (NYSE: [ TEVA ]) we welcome investors to visit: [ www.TradersInsight.net/r/cnbc/24c9_TEVA ].

About Traders Insight
Find direction and insight with TradersInsight.net. Our model of enabling open collaboration between members is breaking new ground into the investment community. By tapping into the resources of the community, we are crowd-sourcing our reach. As a result -- we have been able to identify some of the greatest moving companies on the market today. The evidence is in the results, join today and experience what you've been missing.